You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nintedanib

Showing 1 - 25 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • (no location specified)
May 15, 2023

Healthy Trial (BI 1015550, Nintedanib, Pirfenidone)

Not yet recruiting
  • Healthy
  • BI 1015550
  • +2 more
  • (no location specified)
Oct 2, 2023

Idiopathic Pulmonary Fibrosis Trial in Adelaide (taladegib, nintedanib)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Adelaide, South Australia, Australia
    Research Site
Apr 5, 2023

Safety of Nintedanib in Real World in China

Not yet recruiting
  • Pulmonary Fibrosis
  • Beijing, China
    China-Japan Friendship Hospital
Jan 26, 2023

Lymphangioleiomyomatosis Trial in Milan (Nintedanib)

Completed
  • Lymphangioleiomyomatosis
  • Nintedanib
  • Milan, Italy
    Pneumology unit
Sep 26, 2022

Healthy Subjects Trial in Glendale (Nintedanib, AZD5055)

Not yet recruiting
  • Healthy Subjects
  • Glendale, United Kingdom
    Research Site
Dec 1, 2022

Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

Completed
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • Milton, Massachusetts
    Medicus Economics, LCC
Aug 8, 2022

Appendix Cancer Trial in Charlotte (nintedanib)

Terminated
Has Results
  • Appendix Cancer
  • nintedanib
  • Charlotte, North Carolina
    Levine Cancer Institute
Aug 5, 2022

Novel Coronavirus-induced Lung Fibrosis Trial in Chandigarh (Pirfenidone, Nintedanib)

Active, not recruiting
  • Novel Coronavirus-induced Lung Fibrosis
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research
Sep 30, 2022

NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Nintedanib
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Buffalo, New York
  • +1 more
Nov 8, 2022

Lung Diseases, Interstitial (in Pediatric Populations), Childhood Interstitial Lung Disease (chILD) Trial (nintedanib)

Temporarily not available
  • Lung Diseases, Interstitial (in Pediatric Populations)
  • Childhood Interstitial Lung Disease (chILD)
  • nintedanib
  • (no location specified)
Jan 9, 2023

Healthy Trial in Neu-Ulm (Pirfenidone, GLPG4716, Nintedanib)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Jun 1, 2022

Telangiectasia, Hereditary Hemorrhagic Trial in Lausanne (Nintedanib, Placebo)

Recruiting
  • Telangiectasia, Hereditary Hemorrhagic
  • Nintedanib
  • Placebo
  • Lausanne, Vaud, Switzerland
    Respiratory medicine Department, Lausanne University Hospital
Jul 22, 2022

Idiopathic Pulmonary Fibrosis Trial in Shanghai (HEC585, Pirfenidone, Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Shanghai, China
    Shanghai Xuhui Central Hospital
May 12, 2022

Cough and Dyspnoea in Nintedanib-treated Connective Tissue

Not yet recruiting
  • Lung Diseases, Interstitial
  • Nintedanib
  • (no location specified)
Aug 15, 2022

Bronchiolitis Obliterans Syndrome (BOS), Bronchiolitis Obliterans (BO) Trial in Basel (Nintedanib)

Recruiting
  • Bronchiolitis Obliterans Syndrome (BOS)
  • Bronchiolitis Obliterans (BO)
  • Nintedanib
  • Basel, Switzerland
  • +1 more
May 4, 2022

Lung-transplant Recipients Trial in Suresnes (Nintedanib, Placebo)

Recruiting
  • Lung-transplant Recipients
  • Nintedanib
  • Placebo
  • Suresnes, France
    Foch Hospital
May 2, 2022

INCHANGE - Nintedanib for Changes in Cough and Dyspnea in

Not yet recruiting
  • Lung Diseases, Interstitial
  • Nintedanib
  • (no location specified)
Aug 19, 2022

Trends in Quality of Life in Idiopathic Pulmonary Fibrosis Under

Active, not recruiting
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • Alexandroupoli, Greece
  • +9 more
Aug 22, 2022

Lung Diseases, Interstitial Trial in China (nintedanib, Placebo)

Recruiting
  • Lung Diseases, Interstitial
  • nintedanib
  • Placebo
  • Beijing, China
  • +15 more
Jan 23, 2023

Dose Reduction and Discontinuation With Anti-Fibrotic

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ridgefield, Connecticut
    Boehringer Ingelheim
Mar 24, 2023

Pulmonary Fibrosis, Interstitial Lung Disease, Respiratory Disease Trial in United States (Nintedanib, Placebo)

Recruiting
  • Pulmonary Fibrosis
  • +2 more
  • Nintedanib
  • Placebo
  • Phoenix, Arizona
  • +7 more
Oct 9, 2022

Myositis Associated Interstitial Lund Disease (MA-ILD) Trial in United States (Nintedanib, Placebo, Standard of Care)

Not yet recruiting
  • Myositis Associated Interstitial Lund Disease (MA-ILD)
  • Nintedanib
  • +2 more
  • Los Angeles, California
  • +14 more
Mar 22, 2023

Lung Diseases, Interstitial Trial in Belgium (nintedanib)

Available
  • Lung Diseases, Interstitial
  • nintedanib
  • Aalst, Belgium
  • +13 more
Aug 8, 2022